BiopharmaTrend: Where Tech Meets Bio

BioPharmaTrend

Latest News

Aqemia Secures $7.4M to Expand RNA-Targeting Programs …

Aqemia Secures $7.4M to Expand RNA-Targeting Programs With Physics-Based Generative AI

Aqemia has announced a $7.4 million grant from the France 2030 investment plan to accelerate its work in RNA-targeted drug discovery. The funding will support … Read More

Isomorphic Labs Raises $600M to Advance AI …

Isomorphic Labs Raises $600M to Advance AI Drug Design and Internal Pipeline

Isomorphic Labs has secured $600 million in its first external funding round to accelerate the development of its AI-based drug design engine and support the … Read More

Turn Bio Acquires Vesigen’s Microvesicle Delivery System …

Turn Bio Acquires Vesigen’s Microvesicle Delivery System for Epigenetic Therapies

Turn Biotechnologies, a biotechnology company based in Mountain View, California, announced on March 26, 2025, the acquisition of ARMMs (ARRDC1-Mediated Microvesicles) technology from Vesigen Therapeutics. … Read More

seca Presents Real-Time Body Composition Tracker for GLP-1 Patients

Oxford Nanoimaging Launches ML-Driven Platform for Lipid Nanoparticle Characterization

A Call to Improve the UK Life Sciences Sector, Home to Over 6,800 Companies

Spatial Biology Company Alpenglow Biosciences Unveils 3D Imaging Interface for Light-Sheet Microscopy

YC Startup ReactWise Raises $3.4M in Pre-Seed to Develop AI-Driven Robotic Labs for Drug Manufacturing

Roivant Spinout Debuts AI Model to Combine Biomolecule Structure Prediction and Generation

Read latest news ›››

Latest Insights

Legal and Governance Considerations in AI for …

by Nikhil Pradhan

Legal and Governance Considerations in AI for Drug Discovery: New Paradigms and 2025 Outlook

Just in time for 2025 prediction season, a survey of the emerging AI drug discovery landscape, prepared by Chris Bradbury, has been making the rounds—and … Read More

Combination Therapies May Be the Future of …

by Andreas Dreps, Bea Mann, PhD

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

The field of oncology is experiencing a proliferation of cancer therapies. In 2024 alone, the U.S. Food and Drug Administration (FDA) issued more than 60 … Read More

Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research

by BiopharmaTrend

AI in Drug Safety: From Concept to Reality, The Industry's Path Forward

by Dr. Karthik Muthusamy

Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development

by Bea Mann, PhD

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

by Andreas Dreps, Bea Mann, PhD

The Future of Advanced Therapeutics: Opportunities and Challenges

by Sai Bhamidipati

What CROs Cite as Their Top Clinical Trial Challenges and How They Plan to Overcome Them in 2025

by Megan Deegan

21 Life Science Marketplaces to Try in 2024

by Andrii Buvailo

FTI Survey: Healthcare & Life Sciences Optimism, M&A and AI to Drive 2025 Growth

by BiopharmaTrend

Read all insights ›››

From Our Partners

Read All ›››

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs …

Sponsored by MEDSIR

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology

This AI Startup Joins Forces With NVIDIA's …

Sponsored by RECEPTOR.AI

This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery

How AI Empowers Biomarker-Driven Clinical Trials

Sponsored by Lantern Pharma

How AI Empowers Biomarker-Driven Clinical Trials

Chemistry CROs at a Crossroads: How SpiroChem …

Sponsored by SpiroChem

Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond

Partner Events

View all events ›››

22nd BioPharma Drug Discovery Nexus Conference Belgium

22nd BioPharma Drug Discovery Nexus Conference Belgium

Event Date: April 29, 2026 - April 29, 2026

Location: Belgium (Brussels, Holiday Inn)

Website: Link

London Biotechnology Show 2025

London Biotechnology Show 2025

Event Date: June 18, 2025 - June 19, 2025

Location: United Kingdom (Hall N7 & N8 Bett Global, Excel London, Royal Victoria Dock, 1 Western Gateway, London, UK, England, GB, E16 1XL)

Website: Link

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting

The 12th Aging Research & Drug Discovery Meeting The 11th Aging Research & Drug Discovery Meeting

Event Date: Aug. 25, 2025 - Aug. 29, 2025

Location: Denmark (Ceremonial Hall, University of Copenhagen)

Website: Link

Global Clinical Trials Connect 2025

Global Clinical Trials Connect 2025

Event Date: May 28, 2025 - May 29, 2025

Location: United Kingdom (London)

Website: Link

Case Studies

Read All ›››

QUAISAR Computational Platform for Designing Targeted Protein …

Sponsored by Roivant Sciences

QUAISAR Computational Platform for Designing Targeted Protein Degraders

Revolutionizing Clinical Trials: How AI and Automation …

Sponsored by Trialize

Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days

Bioz Badges — Advanced Data-Widgets for Confident …

Sponsored by Bioz

Bioz Badges — Advanced Data-Widgets for Confident E-commerce

Using End-to-End Wet Lab Automation Combined with …

Sponsored by Arctoris

Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery

Application of AI-driven Xanthos Platform for Designing …

Sponsored by Celeris Therapeutics

Application of AI-driven Xanthos Platform for Designing Protein Degraders

Cyclica's Chemical Probes for DCAF1

Sponsored by Cyclica

Cyclica's Chemical Probes for DCAF1

Identifying High Impact Tissue Sparing E3 Ligases …

Sponsored by Kymera Therapeutics

Identifying High Impact Tissue Sparing E3 Ligases and Their Binders

Busting the PoseBusters v3: AI Docking Software …

Sponsored by RECEPTOR.AI

Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy

Interviews

Read All ›››

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs …

Beyond Traditional Clinical Trials: MEDSIR’s Adaptive Designs and Precision Medicine in Oncology

Rethinking Clinical Trials: Tim Smith on Medable’s …

Rethinking Clinical Trials: Tim Smith on Medable’s Approach to Speed and Efficiency

Targeted Protein Degradation: a New Approach to …

Targeted Protein Degradation: a New Approach to Small Molecule Therapeutics

[Interview] This Company Brings Quantum Tech Into …

[Interview] This Company Brings Quantum Tech Into Protein Design

Most Read

The Explosion of Therapeutic Modalities: Small Molecules, …

The Explosion of Therapeutic Modalities: Small Molecules, Biologics, and Everything in Between

21 Life Science Marketplaces to Try in …

21 Life Science Marketplaces to Try in 2024

14 Companies Using Quantum Theory To Accelerate …

14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)

5 AI-Powered Companies Transforming the Future of …

5 AI-Powered Companies Transforming the Future of Fertility Care